| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 28.09. | Glucotrack, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 24.09. | GlucoTrack Stock Rises 27% After Public Offering Announcement | 2 | RTTNews | ||
| 24.09. | Glucotrack prices $3.1M public offering | 3 | Seeking Alpha | ||
| 24.09. | Glucotrack prices $3.1 million public offering at $2.04/share | 1 | Investing.com | ||
| 24.09. | Glucotrack platziert öffentliches Angebot über 3,1 Millionen US-Dollar zu 2,04 US-Dollar je Aktie | 2 | Investing.com Deutsch | ||
| 18.09. | Glucotrack: Direktor Paul V. Goode tritt wegen möglichem Interessenkonflikt zurück | 4 | Investing.com Deutsch | ||
| 18.09. | Glucotrack, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 18.09. | Glucotrack, Inc. - S-1, General form for registration of securities | - | SEC Filings | ||
| GLUCOTRACK Aktie jetzt für 0€ handeln | |||||
| 11.09. | Glucotrack announces $11.5M financing | 1 | Seeking Alpha | ||
| 11.09. | Glucotrack secures $11.5M in convertible note financing | 1 | Investing.com | ||
| 09.09. | Glucotrack, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 27.08. | Glucotrack announces 1-for-15 reverse stock split | 1 | Seeking Alpha | ||
| 27.08. | Glucotrack, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 27.08. | Glucotrack, Inc. Announces Reverse Stock Split | 281 | Business Wire | 1-for-15 reverse stock split to become effective as of the opening of trading on August 31, 2026
RUTHERFORD, N.J. & LA JOLLA, Calif.--(BUSINESS WIRE)--Glucotrack, Inc. (Nasdaq: GCTK) ("Glucotrack"... ► Artikel lesen | |
| 19.08. | Glucotrack, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 17.08. | Glucotrack regains Nasdaq compliance on equity requirement | 1 | Investing.com | ||
| 06.08. | Glucotrack Secures $5.5 Million Financing Through Equity And Convertible Debt | 1 | pulse2.com | ||
| 05.08. | Glucotrack, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 27.07. | Glucotrack, Inc. - 8-K, Current Report | 5 | SEC Filings | ||
| 17.07. | Glucotrack Gains Slightly on Bridge Financing Deal | - | Baystreet.ca |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 12,360 | +1,64 % | SONDERMELDUNG bei Eckert&Ziegler: Knackt die Aktie jetzt die entscheidende Marke? - Das müssen Sie am Montag wissen! | ||
| TELADOC HEALTH | 5,176 | +0,39 % | Teladoc Health Adds Contactless Vitals and Ambient AI Scribe to Virtual Visit Platform | ||
| SERNOVA BIOTHERAPEUTICS | 0,070 | +1,45 % | Sernova Biotherapeutics, Inc.: Sernova and Seraxis Close US$11.2 Million Financing to Fund Merger to Become BetaNova Biotherapeutics and Advance Type 1 Diabetes Cell Therapy Into Near Term Phase 1/2 Clinical Trial | TORONTO and GERMANTOWN, Md., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics Inc. ("Sernova") (TSX: SVA) (OTC: SEOVF) (FSE/XETRA: PSHO) and Seraxis Holdings, Inc. ("Seraxis") today announced... ► Artikel lesen | |
| SYNLAB | - | - | EQS-News: SYNLAB: Synnovis and Apian partner to advance drone and autonomous robotics in healthcare logistics | EQS-News: SYNLAB
/ Key word(s): Miscellaneous
Synnovis and Apian partner to advance drone and autonomous robotics in healthcare logistics
07.09.2026 / 09:31 CET/CEST
The... ► Artikel lesen | |
| CERENOME | 1,504 | -3,09 % | Cerenome, Inc.: Cerenome Launches CNSide CSF Molecular Profile Tests | HOUSTON, Oct. 06, 2026 (GLOBE NEWSWIRE) -- CNSide Diagnostics, LLC, a wholly owned subsidiary of Cerenome, Inc. (Nasdaq: CNSY) ("Cerenome" or the "Company"), today announced the commercial launch... ► Artikel lesen | |
| NUGEN MEDICAL DEVICES | 0,011 | -100,00 % | NuGen Medical Devices Inc.: NuGen Announces Loan Agreement with Sol-Millennium Medical HK Limited | Toronto, Ontario--(Newsfile Corp. - September 21, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company") is pleased to announce the entering into of a loan agreement (the "Loan Agreement")... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 2,180 | -0,91 % | Atossa Therapeutics schließt CVR-Vereinbarung für Erlöse aus FDA-Prüfgutschein | ||
| SONOMA PHARMACEUTICALS | 2,350 | -100,00 % | Sonoma Pharmaceuticals, Inc. - 8-A12B/A, Registration of securities | ||
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc. - 8-K, Current Report | ||
| UNIDOC HEALTH | 0,040 | -11,11 % | XFRA L7T: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| TANDEM DIABETES | 14,200 | -1,39 % | Tandem Diabetes Care, Inc.: Tandem Mobi Automated Insulin Delivery System Now Available in Twelve International Markets | Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that Tandem Mobi, the world's smallest, durable automated insulin delivery... ► Artikel lesen | |
| CO-DIAGNOSTICS | 1,115 | 0,00 % | Co-Diagnostics Reports Second Quarter 2026 Financial Results | Advancing Commercialization Through FDA Submission, Global Clinical Progress and Manufacturing Expansion
Strengthening Integrated Co-Dx PCR Platform Through Scientific... ► Artikel lesen | |
| MEDIVOLVE | - | - | Medivolve Inc (2): OSC cites Bharti, Said for disclosure failures | ||
| QUIDELORTHO | 11,435 | -4,55 % | Sanjeev Sharma wird neuer Leiter Investor Relations bei QuidelOrtho | ||
| QUEST DIAGNOSTICS | 201,30 | -2,38 % | Dividendenbekanntmachungen (06.10.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ANGLO AMERICAN PLC ADR US03485P4090 0,115 USD EUR BANK CENTRAL ASIA TBK ADR US69368G1058 0,035 USD EUR BANK OF NOVA SCOTIA CA0641491075 1... ► Artikel lesen |